ImmunityBio
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2014-01-01
- Employees
- 628
- Market Cap
- $2.9B
- Website
- http://www.immunitybio.com
- Introduction
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong ...
Phase 3 Clinical Trial Of ANKTIVA Plus NIVOLUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 460
- Registration Number
- NCT06745908
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-11-29
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06710288
- Locations
- 🇺🇸
Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States
Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06334991
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06061809
- Locations
- 🇺🇸
Providence Medical Foundation, Fullerton, California, United States
🇺🇸Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06040918
- Locations
- 🇺🇸
Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States
A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL
- Conditions
- Interventions
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT06022224
- Locations
- 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)
- Conditions
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05981131
- Locations
- 🇺🇸
Island Urology, Honolulu, Hawaii, United States
IBRX-042 In Subjects With HPV-Associated Tumors
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT05976828
- Locations
- 🇺🇸
Chan Soon-Shiong Institute for Medicine (CSSIFM), El Segundo, California, United States
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05618925
- Locations
- 🇺🇸
Hoag Memorial Hospital, Newport Beach, California, United States
THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines
- Conditions
- Interventions
- First Posted Date
- 2022-05-11
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05370040
- Locations
- 🇿🇦
Wits Vida, Johannesburg, South Africa